Clinically, elevated levels of endogenous GLP-1 have been observed in patients with sepsis (6.35-fold increase), end-stage renal disease (4.46-fold), and burns (2.96-fold), indicating a common physiological response to critical illness (Lebherz et al., 2017)
Ashley (00:29:55): But they increased
Other rows cover inadequate caloric or protein intake, poor hydration, baseline anemia or low iron stores, sleep disruption, and concurrent illness or high stress, each mapped to how it shifts fatigue risk
Clinical and preclinical data support the efficacy of GLP-1 RAs in resolving steatosis and SLD progression in metabolic contexts
doi: 10.1111/apa.15168 53
Supplied as lyophilized powder vials, injectables, capsules, or sprays and used exclusively in laboratory and in-vitro research settings not drugs, supplements, or therapeutic products